Free Subscription

  • Access daily briefings and unlimited news articles

Premium

From $39.95 per year
  • Quarterly magazine and digital
  • Indepth executive interviews
  • Unlimited news and insights
  • Expert opinion and analysis

H7N9

H7N9 Archives

EpiVax receives funding for H7N9 vaccine trial

Immunology company wins $600,000 grant to create new vaccine for avian influenza virus.